Plasmid-determined antibiotic resistance is widespread in clinical isolates of bacteria. Most determinants of resistance (r-determinants) have no homology with the chromosomal genes of their hosts and Watanabe (1) has suggested that rdeterminants exist "somewhere" in nature as a reservoir of chromosomal genes and that, under the appropriate selection pressures, they were "picked-up" by promiscuous sex factors and, directly or indirectly, transferred to their present hosts.
Plasmid-determined antibiotic resistance is widespread in clinical isolates of bacteria. Most determinants of resistance (r-determinants) have no homology with the chromosomal genes of their hosts and Watanabe (1) has suggested that rdeterminants exist "somewhere" in nature as a reservoir of chromosomal genes and that, under the appropriate selection pressures, they were "picked-up" by promiscuous sex factors and, directly or indirectly, transferred to their present hosts.
It has been demonstrated (2-8) that many antibiotic-producing bacteria contain antibiotic-modifying enzymes that are related to those that determine antibiotic resistance in plasmid-containing bacteria. To date, aminoglycoside O-phosphorylating and N-acetylating enzymes (2) , aminocyclitol O-phosphorylating enzymes (3) (4) (5) (6) and chloramphenicol acetyltransferase (EC 2.3.1.28) (7, 8) have been detected in antibiotic-producing strains; these enzymes have substrate ranges similar to the plasmid-mediated enzymes found in various Gram-positive and Gram-negative bacteria. It has been suggested, therefore, that antibiotic-producing organisms might represent the origin of r-determinants (2) (3) .
Support for this notion would come from the demonstration of protein or nucleic acid relationships between antibioticproducing organisms and plasmid-containing antibiotic-resistant bacteria. One can also ask if a gene coding for antibioticmodification in an antibiotic-producing organism could be transplanted to unrelated bacteria such as Escherichia coli; and whether or not this gene would determine antibiotic resistance in the latter.
Abbreviations: ColEl, colicinogenic factor El; ColEl-ApR, plasmid directing production of colicin El 
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Bacillus circulans NRRL B-3312 is used for the production of butirosin, an antibiotic closely related to neomycin. This nonpathogenic strain contains a phosphotransferase that has a similar activity profile to the neomycin phosphotransferases of clinical isolates (9) . Using a colicinogenic factor E1(ColE1) derivative as a vehicle, we have transferred the gene determining neomycin phosphotransferase from B. circulans to E. coli. By virtue of this phosphotransferase the hybrid plasmid confers resistance to a variety of aminoglycosides in its E. coli host. The resistant phenotype so obtained is typical of that associated with neomycin phosphotransferases that occur "naturally" on plasmids in organisms such as E. coli.
MATERIALS AND METHODS
Bacterial Strains. B. circulans NRLL B-3312 (9) which produces butirosins (But) A and B was obtained from Tom Pridham, Northern Regional Research Laboratory. B. circulans ATCC 4513 was purchased from the American Type Culture Collection. E. coli C-la (10) was obtained from W. F. Dove. Plasmids JR67 (1w, Sm, Neo) (11) and RP4 (P, Amp, Tet, Neo) (12) were introduced into E. coli C-la by conjugation. E. coli C600 harboring ColEl-ApR (RSF 2124) (13) was obtained from S. Falkow. ColEl-ApR consists of a ColEl factor which acquired TnA, a 3.2 megadalton transposable element. TnA specifies resistance to ampicillin through synthesis of the TEM-fl-lactamase.
DNA Preparation. B. circulans NRLL B-3312 DNA was purified by phenol extraction and banding in a cesium chloride gradient. Covalently closed circular plasmid DNA from E. coli C600/ColEl-ApR and hybrid plasmid DNA from transformants isolated in this study were purified as described by two successive bandings in cesium chloride-ethidium bromide (14, 15) . Bacteriophage Xcb2 DNA was provided by W. Szybalski.
Enzymes. Restriction endonucleases EcoRI and Sna I were purified and used as described (14) . Restriction endonuclease BamH I was prepared according to Wilson and Young (16 ) and after 3 hr at 40, 50 ,u was removed to monitor the ligation reaction by electrophoresis as described (14); the remainder of the reaction mixture (100,ul) was incubated on ice for 17 hr. Transformation and Selection. The procedure used for transformation was that described by Mandel and Higa (18) . After transformation, the cells were plated on medium containing ampicillin (100 Mg/ml) and neomycin (20 Mg/ml). Colonies were picked and tested for colicin production by the overlay procedure of Fredericq (19) and for immunity to colicin El by testing growth of clones in the presence of purified colicin El. Five transformants were tested further for the synthesis of neomycin phosphotransferase by the enzymatic assay described below. Plasmid DNA extracted from the same five transformants was tested for increased molecular weight by agarose gel electrophoresis, by using ColEl-ApR as an internal standard, and for the presence of foreign DNA fragments by the same technique after digestion with EcoRI endonuclease.
Enzymatic Assays. The extracts for assay were prepared as follows: 100 ml of an exponential culture in broth was harvested and washed once in 10 mM Tris-HCI (pH 8.0), 1 mM EDTA, and resuspended in 2 ml of 10 mM Tris-HCI (pH 7.8), 10 mM MgCl2, 25 mM NH4CI, 0.6 mM 2-mercaptoethanol. The cells were subjected to four 60 sec bursts from a sonicator at 65 W output. The resulting suspension was centrifuged at 105,000 X g for 45 min and the supernatant removed. The enzyme assays were performed as described by Haas and Dowding (20) .
DNA Base Composition. A determination of base composition was made after buoyant density measurements (15) . Electron microscopy (15) and heteroduplex analysis (21) were performed as described. The method of Steers et 
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Construction of ColE1-ApR B. circulans Plasmids. Total DNA from B. circulans and ColEl-ApR DNA, treated with EcoRI endonuclease and ligated, was used to transform E. coli C-la. Clones were selected for their ability to grow in the presence of ampicillin and neomycin. The transformants were tested for (i) inability to produce colicin El, (ii) immunity to colicin E1, (iii) synthesis of neomycin phosphotransferase, and (iv) presence of extrachromosomal DNA. Plasmid DNA was isolated and examined (i) by agarose gel electrophoresis, by using the ColEl-ApR vehicle as internal molecular weight standard, and (ii) after digestion with EcoRI endonuclease, for the presence of fragments of B. circulans DNA. Forty out of the 67 transformants were unable to produce colicin El but retained immunity to colicin El. One of the transformants was studied further and its hybrid plasmid was called pAT6.
Properties of the Transformants. Phenotypic Properties. The minimal inhibitory concentrations of a variety of aminoglycosides for the antibiotic-producing B. circulans NRRL B-3312 were determined, by using the nonproducing B. circulans cells (ATCC 4513) as a reference (Table 1) . Except for butirosin and, at a lesser extent ribostamycin, the neomycin phosphotransferase does not confer antibiotic resistance to the antibiotic-producing strain. The minimal inhibitory concentrations of various antibiotics for E. coli C-la and E. coli C- (20) and determine aminoglycoside resistance phenotypes in E. coli C-la similar to that due to pAT6.
Enzymatic Properties. The aminoglycoside substrate profiles of neomycin phosphotransferases extracted from B. circulans NRRL B-3312 or E. coli C-la/pAT6 are very similar (Fig. 1) (Fig. 2) .
Base Composition of the Hybrid Plasmid DNA and Its Constituents. The hybrid plasmid pAT6 DNA was analyzed by CsCl density gradient ultracentrifugation (Fig. 3, Table 2 was used as an internal standard for pAT6 length measurement. For each DNA species, the histogram is plotted in increments equal to 5% of the mean contour length of the given species.
(1.707). Thus, the B. circulans fragment has a G+C content (54.5%) which is slightly higher than that of the B. circulans chromosome (53.5%); the latter value represents an average for the whole genome.
Size Distribution of Plasmid DNAs. Analysis by electron microscopy was performed on the DNAs of the two plasmids ColE1-ApR and pAT6. Contour Table 2 ). This latter value is in close agreement with a previous report (13) . The molecular weight of the B. circulans fragment is therefore 5 X 106 (SD: 0.6); this agrees with the value based on agarose gel electrophoresis (4.8 X 106).
Analysis of DNA Heteroduplexes by Electron Microscopy. The hybrid plasmid pAT6 was characterized by heteroduplex analysis and compared with ColEl-ApR (Fig. 5A) and ColEl (Fig. 5B) . As already described (23), the ampicillin transposable element TnA exhibits a short stem of approximately 140 base pairs (Fig. 5B) . By contrast, examination of a large number of single-stranded molecules failed to show the presence of an inverted repeat on the B. circulans fragment. Contour length measurements of such heteroduplexes are shown in Fig. 5C . The values obtained for the molecular weight of TnA (3.4 X 106, SD: 0.4) and the position of its site of insertion compared to the EcoRI endonuclease recognition sequence are in good agreement with those reported earlier (13, 23 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1977) 1003 presumably prevents further uptake of the antibiotic by the cell, by an unknown mechanism (25) . It is all the more surprising and further support for our hypothesis that the B. circulans neomycin phosphotransferase establishes resistance in E. coli by the same mechanism: when E. coli C-la/pAT6 was grown in the presence of neomycin, no detectable change in antibiotic concentration was found.
More generally, the problem addressed in this study concerns the source of genes for biosynthesis and/or modification of secondary metabolites. Although the origins of primary metabolite synthesis probably go back to the most primitive organisms, the origins of secondary metabolite biosynthesis or modification need not necessarily have followed the same route and could conceivably have been dispersed in a lateral or even retrograde direction. The determinants of antibiotic biosynthesis and associated antibiotic modification constitute a pertinent example.
The finding of the synthesis of such similar "unlikely" molecules as neomycin and butirosin in such diverse species as Streptomyces fradiae and B. circulans, respectively, coupled with the presence of two neomycin phosphotransferases of similar substrate spectra in both species (2, 9) suggests the possibility that the antibiotic-producing organisms may be the progenitors of resistance-associated enzymes. At present, the roles of the modifying enzymes associated with antibiotic production are unknown. In any case, both chromosomal and plasmid genes for antibiotic modification from Gram-positive organisms are effectively expressed in Gram-negative bacteria. This suggests (but by no means proves) that relatively facile interspecies dispersal of genes for antibiotic biosynthesis and modification (resistance) may occur in nature.
The B. circulans neomycin phosphotransferase, when present in B. circulans, determines resistance to butirosin and low levels of ribostamycin, although it catalyzes efficient phosphorylation of a number of aminoglycosides including neomycin. In contrast, when present in E. coli, this same determinant specifies a level of resistance to these antibiotics and neomycin an order of magnitude higher. This is consistent with the expression of other plasmid-coded neomycin phosphotransferases such as those of JR67 and RP4 (Table 1 ). The fact that the butirosinproducing strain is not resistant to high levels of aminoglycosides may be a function of the localization of the enzyme in the cell and its association with transport systems for these antibiotics. Regulation of enzyme synthesis may also contribute to the observed quantitative differences; the B. circulans neomycin phosphotransferase is associated with a multicopy plasmid in E. coli (13) .
These results are consistent with the notion that antibioticproducing organisms are the source of genes for resistanceplasmids. More convincing proof of a direct relationship might come from studies of nucleic acid and protein homologies between representative strains. There remains, also, the problem of how these genes have undergone natural "genetic engineering" and interspecies transfer from an antibiotic-producing Gram-positive bacterium ultimately to Gram-negative clinical isolates.
